NCT01754857
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +17 more
- Locations
-
- University of Wisconsin Madison, Wisconsin, United States
Clinical trial condition
Lymphoproliferative Disorders
Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.
10,104 public trials
2,042 recruiting studies
Lymphoproliferative Disorders trial results
NCT04950998
- Conditions
- Behavior, Brain Diseases, Central Nervous System Diseases, +22 more
- Locations
-
- University of Southern California Los Angeles, California, United States
- Conditions
- Advanced Solid Tumor, Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, +15 more
- Locations
-
- University of Arizona Cancer Center Tucson, Arizona, United States
- Moffitt Cancer Center Tampa, Florida, United States
- Columbia University Medical Center New York, United States
NCT05918809
- Conditions
- Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Novartis East Hanover, New Jersey, United States
NCT05448196
- Conditions
- Behavior, Behavioral Symptoms, Blood Protein Disorders, +16 more
- Locations
-
- Penn Medicine Philadelphia, Pennsylvania, United States
NCT03364231
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +19 more
- Locations
-
- TG Therapeutics Investigational Trial Site Washington D.C., District of Columbia, United States
- TG Therapeutics Investigational Trial Site Boston, Massachusetts, United States
- TG Therapeutics Investigational Trial Site Hackensack, New Jersey, United States
- TG Therapeutics Investigational Trial Site New York, United States
Completed
CART19 to Treat B-Cell Leukemia or Lymphoma That Are Resistant or Refractory to Chemotherapy
NCT01029366
- Conditions
- Adult Acute Lymphoblastic Leukemia in Remission, B-cell Adult Acute Lymphoblastic Leukemia, B-cell Chronic Lymphocytic Leukemia, +45 more
- Locations
-
- Abramson Cancer Center of The University of Pennsylvania Philadelphia, Pennsylvania, United States
NCT00458653
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Dana-Farber Cancer Institute/Brigham & Women's Hospital Boston, Massachusetts, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
- Rambam Medical Center Haifa, Israel
NCT00121719
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +8 more
- Locations
-
- Netherlands Cancer Institute- Antoni Van Leeuwenhoek Hospital Amsterdam, Netherlands
- Gartnavel General Hospital Glasgow, United Kingdom
Completed
CART-19 for Multiple Myeloma
NCT02135406
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
- Locations
-
- Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States